Skip to main content

Table 3 Clearances of topiroxostat and its metabolites by a dialyzer by use of an arterio-venous method

From: Effects, safety, and plasma levels of topiroxostat and its metabolites in patients receiving hemodialysis

 

Pre-dialyzer concentration

Post-dialyzer concentration

Clearance (mL/min)

Topiroxostat(μmol/L)

0.269 ± 0.164

0.216 ± 0.166

55.9 ± 31.1

N-Oxide (μmol/L)

0.0812 ± 0.0277

0.0317 ± 0.0190

143.9 ± 37.0

N 1-Glucuronide (μmol/L)

3.21 ± 1.00

0.81 ± 0.64

179.0 ± 41.1

N 2-Glucuronide (μmol/L)

0.853 ± 0.412

0.144 ± 0.121

192.9 ± 37.0

Albumin (g/L)

32.8 ± 5.2

32.5 ± 5.1

2.3 ± 6.7

BUN (mmol/L)

18.8 ± 7.6

1.3 ± 1.0

217.2 ± 27.8

Creatinine (μmol/L)

769.8 ± 164.4

169.4 ± 40.7

179.4 ± 20.4

Serum uric acid (μmol/L)

224.0 ± 66.4

46.6 ± 17.4

184.0 ± 26.2

  1. Mean ± SD. n = 6